Predictors of smoking severity in patients with schizophrenia and alcohol use disorders.

The goal of the present study was to identify predictors of smoking severity in patients with schizophrenia and co-occurring alcohol use disorders (AUD). Our hypothesis was that negative symptoms of schizophrenia, severity of depression, male gender, drinking severity, and recreational drug use were associated with increased smoking. Clinical data, including demographic variables, alcohol and substance use severity, psychiatric medications, severity of depression, positive and negative symptoms of schizophrenia were analyzed in a cohort of 90 patients with schizophrenia or schizoaffective disorder and AUD. Eighty-eight percent of participants were smokers, they smoked an average of 15 cigarettes/day. Zero-inflated negative binomial (ZINB) regression analyses demonstrated that alcohol use severity, gender, and severity of negative symptoms were not predictive of the number of cigarettes smoked. Smoking severity was positively related to Caucasian race, psychosis severity (Positive and Negative Syndrome Scale [PANSS] general score), and medications (conventional antipsychotics). Subjects who used recreational drugs smoked less. In summary, severe, treatment resistant schizophrenia, and conventional antipsychotic treatment is associated with heavy smoking in patients with schizophrenia and AUD regardless of gender or alcohol use.

[1]  S. Heishman,et al.  Meta-analysis of the acute effects of nicotine and smoking on human performance , 2010, Psychopharmacology.

[2]  R. Ploutz-Snyder,et al.  Medical comorbidity in patients with schizophrenia and alcohol dependence , 2009, Schizophrenia Research.

[3]  K. Fagerström,et al.  Management of smoking cessation in patients with psychiatric disorders , 2009 .

[4]  D. Drobes,et al.  Nicotine self‐medication of cognitive‐attentional processing , 2009, Addiction biology.

[5]  W. Riley,et al.  Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. , 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[6]  G. Kaplan,et al.  Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls. , 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[7]  E. Lindström,et al.  Nicotine use and its correlates in patients with psychosis , 2007, Acta psychiatrica Scandinavica. Supplementum.

[8]  L. Dixon,et al.  Correlates of severity of smoking among persons with severe mental illness. , 2007, The American journal on addictions.

[9]  J. de Leon,et al.  Subjective effects and the main reason for smoking in outpatients with schizophrenia: a case-control study. , 2007, Comprehensive psychiatry.

[10]  J. Kaprio,et al.  Smoking behaviour as a predictor of depression among Finnish men and women: a prospective cohort study of adult twins , 2006, Psychological Medicine.

[11]  G. Wiedemann,et al.  Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions? , 2006, European Archives of Psychiatry and Clinical Neuroscience.

[12]  A. Green,et al.  Comorbid schizophrenia and substance abuse. , 2006, The Journal of clinical psychiatry.

[13]  R. Young,et al.  Smoking and Schizophrenia: Is Symptom Profile Related to Smoking and which Antipsychotic Medication is of Benefit in Reducing Cigarette use? , 2006, The Australian and New Zealand journal of psychiatry.

[14]  J. Leon,et al.  A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors , 2005, Schizophrenia Research.

[15]  Suchitra Krishnan-Sarin,et al.  Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. , 2005, Archives of general psychiatry.

[16]  J. de Leon,et al.  Nicotine dependence and symptoms in schizophrenia , 2005, British Journal of Psychiatry.

[17]  H. Nybäck,et al.  Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls , 2005, European Psychiatry.

[18]  L. Malchy,et al.  Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences , 2004, Schizophrenia Research.

[19]  R. Procyshyn,et al.  A comparison of smoking behaviours between patients treated with clozapine and depot neuroleptics , 2001, International clinical psychopharmacology.

[20]  Robert C. Smith,et al.  Effects of Cigarette Smoking on Psychopathology Scores in Patients With Schizophrenia: An Experimental Study , 2001, Substance abuse.

[21]  Veena Kumari,et al.  Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia , 2001, Human psychopharmacology.

[22]  D. Ziedonis,et al.  Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. , 2000, The American journal of psychiatry.

[23]  E. Levin,et al.  Haloperidol increases smoking in patients with schizophrenia , 1995, Psychopharmacology.

[24]  J. Addington,et al.  Assessing Depression in Schizophrenia: The Calgary Depression Scale , 1993, British Journal of Psychiatry.

[25]  J. Madden Alcohol and depression. , 1993, British journal of hospital medicine.

[26]  D. Metzger,et al.  The Fifth Edition of the Addiction Severity Index. , 1992, Journal of substance abuse treatment.

[27]  D S Rae,et al.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. , 1990, JAMA.

[28]  M. Jann,et al.  Clinical Pharmacokinetics of the Depot Antipsychotics , 1985, Clinical pharmacokinetics.

[29]  J. Fleiss,et al.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.

[30]  K. Kharbanda,et al.  S-adenosyl-L-methionine co-administration prevents the ethanol-elicited dissociation of hepatic mitochondrial ribosomes in male rats. , 2009, Alcoholism, clinical and experimental research.

[31]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.